
News from SfN’s Neuroscience 2024: The brain on GLP-1 agonists
Diabetes and weight loss drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists have widespread effects in the brain, with new research presented at the Society for Neuroscience’s Neuroscience 2024 uncovering potential novel therapeutic benefits and behavioural side effects. About one in eight adults… Read More












